Public Company News

PharmaResearch Announces Supply Agreement for Rejuran in Brazil

SEONGNAM, South Korea, Feb. 11, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEOJihoon Sohn), a leading regenerative medicine company, announced that it has entered into an exclusive supply agreement for Rejuran with DermaDream, a Brazilian aesthetic company, as part of its preparations for ent...

2026-02-11 14:54 4672

Linkage Global Sustains CES Momentum with Strong Sales Performance

NEW YORK, Feb. 10, 2026 /PRNewswire/ -- Linkage Global Inc. (NASDAQ: LGCB), ("Linkage Global" or the "Company"), a public company that engages in providing cross-border e-commerce integrated services, today announced a continuation of its market momentum following a successful showcase at the 202...

2026-02-11 09:24 4365

Locksley Resources' Underground Mapping Reveals Major New Target Boosting High-Grade Antimony Potential at its Mojave Project Desert Antimony Mine

SAN BERNARDINO, Calif., Feb. 10, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF/ADR: LKYLY) announced a major new target zone revealed by underground mapping at its Desert Antimony Mine (DAM), part of the company's Mojave Project. This notable finding, the Beefeater Shea...

2026-02-10 23:53 8528

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

CAMBRIDGE, Mass., Feb. 10, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", 03696.HK), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), China Medical System Holdings Limited ("CMS", 867.HK/8A8.SG), an open-platform innovative company linking pharmaceuti...

2026-02-10 21:00 6918

Robo.ai and DaBoss.AI Establish Joint Venture to Launch Distributed Embodied AI Data Platform

DUBAI, UAE, Feb. 10, 2026 /PRNewswire/ -- Robo.ai Inc. (NASDAQ: AIIO), a Nasdaq-listed company, today announced the execution of a definitive joint venture agreement with DaBoss.AI Inc.,an embodied intelligence data technology company based in Silicon Valley.

2026-02-10 20:20 6111

ECARX Announces Completion of the Final Tranche of US$100 million Convertible Notes

LONDON, Feb. 10, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced that the aggregateUS$100 million in convertible notes (the "2025 Notes") contemplated by the convertible note purchase agreement entered into onNove...

2026-02-10 20:17 4803

Eason Technology's Subsidiary Invests $1 Million in Clean Energy Private Investment Fund

Enters 24/7 Carbon-free Energy Sector HONG KONG, Feb. 10, 2026 /PRNewswire/ -- Eason Technology Limited ("Eason" or the "Company") (NYSE American: DXF), today announced that Its subsidiary entered into a definitive agreement to make a strategic investment of US$1 million in Shou Chang Energy Pri...

2026-02-10 19:55 6177

CHINA YUCHAI INTERNATIONAL TO ANNOUNCE UNAUDITED 2025 SECOND-HALF AND FULL YEAR FINANCIAL RESULTS ON FEBRUARY 24, 2026

- Earnings Call to Begin at 8:00 A.M. EST – SINGAPORE, Feb. 10, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company"), announced today that it will be releasing its 2025 unaudited second-half and full year financial results on Tuesday, February 24,...

2026-02-10 19:00 5964

Tencent Music Entertainment Group to Report Fourth Quarter and Full Year 2025 Financial Results on March 17, 2026

SHENZHEN, China, Feb. 10, 2026 /PRNewswire/ -- Tencent Music Entertainment Group ("TME", or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, today announced that it will report its unaudited financial results for the fourth quarter and...

2026-02-10 18:00 7659

BioDlink Recognized by Client for Enabling the World's First Dual-Payload ADC to Enter Clinical Trials

* BioDlink received a formal letter of appreciation from Chengdu Kanghong Pharmaceutical Group for its contribution to advancing KH815, the world's first dual-payload antibody–drug conjugate (ADC) to enter clinical development. * BioDlink enabled IND approval 1.5 months ahead of schedule throu...

2026-02-09 21:00 5990

Acer Announces January 2026 Revenues at NT$21.08 Billion, Up 39.8% Year-on-year, Highest January Revenue Post Pandemic

TAIPEI, Feb. 9, 2026 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues forJanuary 2026 at NT$21.08 billion, up 39.8% year-on-year (YoY), the highest January revenue post pandemic. Highlights in January include: * Revenues from notebook PCs grew by 50.6% YoY * Reven...

2026-02-09 20:43 5779

Trip.com Group Limited to Report Fourth Quarter and Full Year of 2025 Financial Results on February 25, 2026 U.S. Time

SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961), a leading one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours and corporate travel management, will announce its fourth quarter and full year of 2025 fina...

2026-02-09 18:00 7997

ATRenew Discusses Strategies for Scaling Global Circularity at Circular Markets London

SHANGHAI, Feb. 9, 2026 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced it engaged as the only voice fromChina in high-level dialogue on the infrastructur...

2026-02-09 16:00 6015

Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne® TEER System

HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application for its internally developedGeminiOne Transcatheter Edge-to-Edge Repair (TEER) System f...

2026-02-09 14:00 6372

SOHU.COM REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 UNAUDITED FINANCIAL RESULTS

BEIJING, Feb. 9, 2026 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today reported unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2025. Fourth Quarter Highlights ...

2026-02-09 13:00 6542

Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology

SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metaboli...

2026-02-08 18:05 6745

Neurophet Secures FDA 510(k) Clearance for "Neurophet AQUA AD Plus," Marking Its Third U.S. Regulatory Milestone

* Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease imaging analysis * Advanced analysis of neuroimaging features associated with cerebral microbleeds and edema supports imaging-based clinical decision-making and accelera...

2026-02-06 22:00 10566

The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector

FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider inChina, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen trainin...

2026-02-06 21:30 7800

Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology

CAMBRIDGE, Mass., Feb. 6, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico")  (3696.HK),  a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the appointment ofHalle Zhang, PhD (Med), as Vice President, Clinical Development – Oncology. Dr. Z...

2026-02-06 21:00 8182

Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system

* Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards * Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals * Validated system provides reliable, consistent carbon footprint data for clients I...

2026-02-06 21:00 9586
1 ... 13141516171819 ... 772